摘要
目的探讨冠心病患者血清超敏C反应蛋白(hs-CRP)测定的临床价值。方法选择临床诊断为冠心病的患者82例及健康对照者78例,采用免疫透射比浊法分别对上述病例组及对照组进行超敏C反应蛋白含量测定。结果冠心病患者超敏C反应蛋白含量均高于正常对照组,差异有非常显著性(P<0.01);冠心病患者各组间超敏C反应蛋白含量也具有高度显著性差异(P<0.01)。结论血清超敏C反应蛋白含量的测定,对冠心病的发生、发展及预后具有预测价值。
Objective To assess the clinical value of serum high sensitivity C reactive protein(hs-CRP) detected in coronary heart disease(CHD).Methods The hs-CRP in CHD patients(n=82) and normal control(n=78) was detected with transmission immunoturbidimetry(ITM).All patients were clinical diagnosis.Results The concentrations of hs-CRP in CHD patients are all higher than the control(P<0.01),There were also significantly different among the sub groups of patients(P<0.01).Conclusion The detection of serum hs-CRP has predictive value for the occurrence,development and prognosis of CHD.
出处
《分子诊断与治疗杂志》
2009年第4期253-254,共2页
Journal of Molecular Diagnostics and Therapy
关键词
冠心病
超敏C反应蛋白
临床价值
Coronary heart disease(CHD)
High sensitivity C reactive protein
Clinical value
